What stage is typical when MDS is first diagnosed

Understanding MDS Stage at Diagnosis

This is an important question, and the answer might surprise you: MDS doesn't use traditional "stages" like solid cancers do (Stage 1, 2, 3, 4). Instead, doctors use risk categories to describe how serious the disease is and how quickly it might progress.

How MDS Risk is Classified

According to the NCCN Guidelines for Myelodysplastic Syndromes, MDS is categorized into risk groups based on several factors:

Risk Categories:

• Very Low-Risk
• Low-Risk
• Intermediate-Risk
• High-Risk

These categories help doctors predict:

• How likely the disease is to progress to acute myeloid leukemia (AML)
• How quickly blood counts might worsen
• What treatment approach makes sense

What Determines Risk Level?

Your risk category is based on a combination of findings:

1. Blast percentage – How many immature blood cells (blasts) are in your bone marrow (lower percentages = lower risk)
2. Cytogenetics – Chromosome abnormalities found in bone marrow cells
3. Specific gene mutations – Certain mutations like TP53, ASXL1, and RUNX1 are associated with worse prognosis
4. Blood count abnormalities – How low your red blood cells, white blood cells, or platelets are

What's Typical at Diagnosis?

Most patients are diagnosed with lower-risk MDS – meaning very low, low, or intermediate-risk disease. This is actually good news because lower-risk MDS often progresses more slowly and may not require immediate intensive treatment.

However, about 20-30% of patients present with higher-risk disease at diagnosis, which requires more aggressive treatment approaches.

Why This Matters for You

Your specific risk category will guide your treatment plan. According to NCCN Guidelines, lower-risk patients might start with supportive care (like blood transfusions or growth factors), while higher-risk patients typically need more active treatments like hypomethylating agents (azacitidine or decitabine).

Questions to ask your doctor:

1. What is my specific risk category, and what does that mean for my prognosis?
2. Which factors (blasts, mutations, cytogenetics) most influence my risk level?
3. How often will my risk category be reassessed?
4. Does my risk category change my treatment recommendations?
5. Are there any clinical trials appropriate for my specific risk level?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.